Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-01 @ 3:09 AM
Study NCT ID:
NCT04727151
Status:
TERMINATED
Last Update Posted:
2025-06-08
First Post:
2021-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
TAC T-cells for the Treatment of HER2-positive Solid Tumors
Sponsor:
Triumvira Immunologics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TAC01-HER2-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |